Cargando…

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs

Rational drug design implies usage of molecular modeling techniques such as pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking to explain the activity of biomolecules, define molecular determinants for interaction with the drug target, and design more efficient drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagic, Zarko, Ruzic, Dusan, Djokovic, Nemanja, Djikic, Teodora, Nikolic, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960140/
https://www.ncbi.nlm.nih.gov/pubmed/31970149
http://dx.doi.org/10.3389/fchem.2019.00873
_version_ 1783487727321219072
author Gagic, Zarko
Ruzic, Dusan
Djokovic, Nemanja
Djikic, Teodora
Nikolic, Katarina
author_facet Gagic, Zarko
Ruzic, Dusan
Djokovic, Nemanja
Djikic, Teodora
Nikolic, Katarina
author_sort Gagic, Zarko
collection PubMed
description Rational drug design implies usage of molecular modeling techniques such as pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking to explain the activity of biomolecules, define molecular determinants for interaction with the drug target, and design more efficient drug candidates. Kinases play an essential role in cell function and therefore are extensively studied targets in drug design and discovery. Kinase inhibitors are clinically very important and widely used antineoplastic drugs. In this review, computational methods used in rational drug design of kinase inhibitors are discussed and compared, considering some representative case studies.
format Online
Article
Text
id pubmed-6960140
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69601402020-01-22 In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs Gagic, Zarko Ruzic, Dusan Djokovic, Nemanja Djikic, Teodora Nikolic, Katarina Front Chem Chemistry Rational drug design implies usage of molecular modeling techniques such as pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking to explain the activity of biomolecules, define molecular determinants for interaction with the drug target, and design more efficient drug candidates. Kinases play an essential role in cell function and therefore are extensively studied targets in drug design and discovery. Kinase inhibitors are clinically very important and widely used antineoplastic drugs. In this review, computational methods used in rational drug design of kinase inhibitors are discussed and compared, considering some representative case studies. Frontiers Media S.A. 2020-01-08 /pmc/articles/PMC6960140/ /pubmed/31970149 http://dx.doi.org/10.3389/fchem.2019.00873 Text en Copyright © 2020 Gagic, Ruzic, Djokovic, Djikic and Nikolic. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Gagic, Zarko
Ruzic, Dusan
Djokovic, Nemanja
Djikic, Teodora
Nikolic, Katarina
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
title In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
title_full In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
title_fullStr In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
title_full_unstemmed In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
title_short In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
title_sort in silico methods for design of kinase inhibitors as anticancer drugs
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960140/
https://www.ncbi.nlm.nih.gov/pubmed/31970149
http://dx.doi.org/10.3389/fchem.2019.00873
work_keys_str_mv AT gagiczarko insilicomethodsfordesignofkinaseinhibitorsasanticancerdrugs
AT ruzicdusan insilicomethodsfordesignofkinaseinhibitorsasanticancerdrugs
AT djokovicnemanja insilicomethodsfordesignofkinaseinhibitorsasanticancerdrugs
AT djikicteodora insilicomethodsfordesignofkinaseinhibitorsasanticancerdrugs
AT nikolickatarina insilicomethodsfordesignofkinaseinhibitorsasanticancerdrugs